CLINICAL_TRIALS
trial_result
· 2026-04-27
Clinical Trial Results: Phase 1 Study to Assess Safety and Efficacy of ANG003 [Phase 1]
Summary
Phase 1 study evaluating ANG003 for safety and efficacy in exocrine pancreatic insufficiency has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anagram Therapeutics, Inc. | Conditions: Exocrine Pancreatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2026-04-27